TABLE 2.
Number added to N-glycan corea | 293T |
Jurkat |
RD |
HepG2 |
CHO |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
MALDI | FT-ICR | MALDI | FT-ICR | MALDI | FT-ICR | MALDI | FT-ICR | MALDIb | FT-ICR | |||
Hex | GlcNAc | Fuc | Errorc | Error | Error | Error | Error | Error | Error | Error | Error | Error |
High-mannose glycans | ||||||||||||
2 | 0 | 0 | 0.675 | 0.004 | 0.498 | −0.007 | 0.582 | 0.008 | 0.690 | −0.002 | 0.089 | 0.002 |
3 | 0 | 0 | 0.750 | −0.005 | 0.540 | −0.006 | 0.660 | −0.003 | 0.773 | −0.001 | 0.109 | 0.000 |
4 | 0 | 0 | 0.634 | 0.000 | 0.569d | −0.003 | 0.628 | 0.003 | 0.761 | 0.001 | 0.121 | 0.003 |
5 | 0 | 0 | 0.787 | 0.004 | 0.601 | −0.004 | 0.685 | 0.003 | 0.817 | 0.000 | 0.128 | −0.001 |
6 | 0 | 0 | 0.840d | 0.002 | 0.649 | −0.003 | 0.742 | −0.001 | 0.880 | 0.003 | 0.137d | 0.000 |
Complex/hybrid glycans | ||||||||||||
1 | 1 | 0 | 0.958 | 0.000 | 0.101 | 0.001 | ||||||
1 | 1 | 1 | 0.751 | 0.657 | 0.771 | 0.110 | 0.000 | |||||
2 | 1 | 0 | 0.752 | 0.657 | 1.043 | 0.106 | ||||||
2 | 1 | 1 | 0.802 | 0.002 | 0.616 | 0.001 | 0.737 | 0.833 | ||||
3 | 1 | 0 | 0.798 | −0.002 | ||||||||
3 | 1 | 1 | 0.838 | −0.005 | 0.780 | 0.000 | ||||||
0 | 2 | 1 | 0.749 | 0.667 | ||||||||
1 | 2 | 0 | 0.727 | 0.674 | 0.818 | 0.107 | ||||||
1 | 2 | 1 | 0.807 | 0.001 | 0.687 | 0.698 | 0.000 | 0.844 | 0.005 | 0.126 | −0.002 | |
2 | 2 | 0 | 0.821 | −0.001 | 0.703 | −0.002 | 0.839 | 0.003 | 0.124 | −0.002 | ||
2 | 2 | 1 | 0.876 | −0.005 | 0.694 | 0.001 | 0.739d | 0.003 | 0.895 | −0.004 | 0.138 | −0.002 |
2 | 2 | 2 | 0.930d | −0.003 | ||||||||
3 | 2 | 0 | 0.883 | −0.002 | 0.752 | 0.008 | 0.920 | 0.000 | 0.115 | |||
3 | 2 | 1 | 0.912 | 0.139 | −0.006 | |||||||
4 | 2 | 0 | 0.009 | |||||||||
0 | 3 | 1 | −0.001 | 0.093 | ||||||||
1 | 3 | 1 | 0.867d | −0.006 | 0.768 | 0.003 | −0.002 | 0.134 | ||||
2 | 3 | 0 | 0.870 | 0.735 | 0.005 | |||||||
2 | 3 | 1 | 0.919 | −0.001 | 0.716 | 0.768 | 0.009 | 0.948 | −0.004 | |||
2 | 3 | 2 | −0.001 | |||||||||
3 | 3 | 0 | 0.895 | −0.008 | 0.000 | 0.792 | 0.942 | −0.005 | 0.127 | −0.002 | ||
3 | 3 | 1 | 0.974 | −0.009 | −0.006 | 0.873 | 0.005 | 1.000d | −0.006 | 0.142 | −0.004 | |
3 | 3 | 2 | 1.099 | −0.006 | ||||||||
0 | 4 | 1 | 0.861 | 0.006 | ||||||||
1 | 4 | 1 | 0.954 | −0.009 | ||||||||
2 | 4 | 1 | 0.968 | −0.005 | 0.785 | −0.001 | 0.918 | −0.009 | 0.102 | |||
3 | 4 | 0 | 1.042 | |||||||||
3 | 4 | 1 | 1.011 | 0.775 | −0.001 | 1.093 | 0.001 | |||||
4 | 4 | 0 | 0.931 | −0.006 | 0.992 | 0.010 | ||||||
4 | 4 | 1 | 1.111 | 0.801 | −0.002 | 0.968 | 1.095 | −0.003 | 0.141 | |||
4 | 4 | 2 | 1.144 | |||||||||
3 | 5 | 1 | 1.112 | 0.268 | ||||||||
4 | 5 | 1 | 1.133 |
a N-glycan core is (GlcNAc)2(Man)3.
b Analyzed by MALDI-TOF/TOF.
c For each glycan detected, error in daltons is shown. The empty lanes means that the glycan was not detected in the particular gp120 preparation.
d Denotes glycans with tandem mass spectra shown in supplemental Fig. S2. Glycans from each gp120 sample were analyzed twice. Relative abundance data from FT-ICR MS spectra are shown in supplemental Table S1.